PRECISION IMMUNOTHERAPEUTICS LIMITED
Significant control: Professor Colin Henry Self (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Precision Immunotherapeutics Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Precision Immunotherapeutics Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
PRECISION IMMUNOTHERAPEUTICS LIMITED is an active private limited company (company number 11663294) incorporated on 6 November 2018, registered in Newcastle Upon Tyne. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 November 2025, showing net assets of −£20k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 247% on the prior period (£14k). Across the last 3 periods on record the net-asset trend is volatile.
By net assets it sits in the bottom quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Professor Colin Henry Self
- owns 75–100% of shares
- holds 50–75% of voting rights
- Mr William Gwyn Cole
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 6 November 20187 yrs ago
- Next accounts due
- 30 August 2027in 308 days
- Confirmation statement due
- 20 November 2026in 25 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | −£20k | — | — | £3,454 | — | — | 0 |
| 30 November 2024 | £14k | — | — | £14k | — | — | 0 |
| 30 November 2023 | £12k | — | — | £13k | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets below zeroNet assets £-20,339 at 30 November 2025
- Net assets down 25% or more on the prior period-246.7% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.04
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 6 November 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 308 days
- Confirmation statement duein 25 days
- Accounts period endNet liabilities £20k · micro accounts
- Accounts period endNet assets £14k · micro accounts
- Accounts period endNet assets £12k · micro accounts
- Incorporated
Similar companies in Newcastle
- SUNDARA PHARMACEUTICALS LTDNewcastle Upon Tyne · inc. Oct 2018
- NANOVERY LIMITEDNewcastle Upon Tyne · inc. Nov 2018
- PEPMOTEC LIMITEDDurham · inc. Feb 2019
- DEVELRX LIMITEDNewcastle Upon Tyne · inc. Jun 2019
- ALPHABIOMICS LTDNewcastle Upon Tyne · inc. Mar 2018
- TREAT-NMD ALLIANCE LTDNewcastle Upon Tyne · inc. Jul 2019
All companies incorporated on 6 November 2018 · in Nov 2018.
Reminders for PRECISION IMMUNOTHERAPEUTICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.